PharVision Advisers’s Brandywine Realty Trust BDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,878
Closed -$43K 71
2026
Q1
$43K Sell
15,878
-50,647
-76% -$152K 0.44% 93
2025
Q4
$194K Sell
66,525
-32,830
-33% -$112K 0.1% 569
2025
Q3
$414K Buy
+99,355
New +$418K 0.23% 72

Other funds holding BDN

PharVision Advisers's BDN Position: Q2 2026 in Review

PharVision Advisers sold out of Brandywine Realty Trust (BDN) in Q2 2026, closing a stake of 15,878 shares — an estimated $43K sold.

PharVision Advisers first reported a position in BDN in Q3 2025 and held it in 3 quarters. The position peaked at $414K in Q3 2025. 233 funds tracked by Wall St. Rank hold BDN as of Q2 2026.

  • PharVision Advisers reported no remaining Brandywine Realty Trust position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 15,878 Brandywine Realty Trust shares in Q2 2026, an estimated $43K.
  • PharVision Advisers first reported a position in Brandywine Realty Trust in Q3 2025 and held it in 3 quarters.
  • PharVision Advisers's Brandywine Realty Trust position peaked at $414K in Q3 2025.
  • 233 funds tracked by Wall St. Rank held Brandywine Realty Trust as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.